Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3
LifeMD (LFMD) Q3 2026 Earnings Call Transcript
LifeMD, Inc. Q3 2026 Earnings Call Summary
Mizuho Maintains Outperform on LifeMD, Lowers Price Target to $6
What LifeMD (LFMD) Said on Its Q3 Earnings Call
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates
LifeMD Reports Third Quarter 2026 Results
LifeMD Q3 EPS $(0.11) Beats $(0.14) Estimate, Sales $44.625M Miss $48.885M Estimate
LifeMD Lowers FY2026 Sales Guidance from $205.500M-$212.500M to $188.000M-$191.000M vs $207.582M Est
LifeMD Sees Q4 Sales $46.000M-$49.000M vs $61.318M Est
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
LifeMD Announces Agreement For Its Pharmacies To Directly Dispense, Ship Eli Lilly's Self-Pay GLP-1 Medicines
LifeMD to Report Third Quarter 2026 Financial Results on November 9
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target
LifeMD: Still Undervalued Despite Earnings Miss
LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker Guidance
LifeMD: What The Bulls Got Wrong
LifeMD (LFMD) Q2 2026 Earnings Call Transcript
LifeMD, Inc. 2026 Q2 - Results - Earnings Call Presentation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.